Literature DB >> 35174970

Clinical application of an algorithm to screen for malignant cells in body fluids using an automated hematology analyzer.

Ha-Eun Cho1, Young Jin Kim1,2, Sun Young Cho1,2, Tae Sung Park1,2, Kyung Sun Park1.   

Abstract

INTRODUCTION: The detection of malignant cells in body fluids (BF) with an automated hematology analyzer has been proposed as an alternative to morphological examination owing to its various advantages; however, its limitations have also been highlighted. In this study, we devised a practical algorithm to screen for malignant cells in BFs using an automated hematology analyzer.
METHODS: A total of 558 BF samples, including 232 cerebrospinal fluid (CSF) samples and 326 non-CSF samples, were consecutively collected. Thereafter, the results obtained using the BF mode of Sysmex XN-350 (Sysmex, Kobe, Japan) were compared with the cytological diagnosis. A cutoff was also established to screen for malignant cells using receiver operating characteristic (ROC) curve analysis based on the final clinical judgment.
RESULTS: The automated hematology analyzer showed a moderate correlation or good agreement with the existing cytological diagnosis. Further, of the ROC curves for detecting malignant cells, the absolute value of highly fluorescent cells on BF (HF-BF) in total body fluids showed the highest area under the curve (0.85 [95% confidence interval 0.82-88], p < .0001, Youden index >7×106 /L, sensitivity 93%, and specificity 65%).
CONCLUSION: An automated hematology analyzer could function as a complement to cytological examination. We propose a practical and comprehensive algorithm for cytological examination that requires low- and high-resolution microscopy based on the absolute value of HF-BF in BF samples suspected of malignancy. This algorithm can more usefully detect malignant cells while taking advantage of the automated analyzer and cytological examination.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  HF-BF; automated hematology analyzer; body fluid; malignancy; sysmex XN-350

Mesh:

Year:  2022        PMID: 35174970     DOI: 10.1111/ijlh.13813

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  1 in total

1.  Screening for malignant tumor cells in serous effusions with an automatic hematology analyzer using a novel diagnostic algorithm.

Authors:  Dehua Sun; Xinru Mao; Taixue An; Xiaojing He; Kai Qiu; Yuhong Luo; Zheyuan Qin; Yongjian He; Tie Xiong; Houmei Feng; Jin Li; Lei Zheng
Journal:  Ann Transl Med       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.